Research & Manuscripts

You can find the full list of my publications on Google Scholar

Select publications

Date	Article | Authors	Journal
9/2023	SPOT/Dx Pilot Reanalysis and College of American Pathologists Proficiency Testing for KRAS and NRAS Demonstrate Excellent Laboratory Performance Zehir A, Nardi V, Konnick EQ, …, Lindeman NI, and Moncur JT	Arch. Pathol. Lab. Med.
8/2023	Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors Franch-Expósito S, Mehine M, Ptashkin RN, …, Berger MF, and Zehir A	Jco Precis Oncol
10/2023	Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing Ptashkin RN, Ewalt MD, Jayakumaran G, …, Zehir A, and Arcila ME	Nat. Commun.
8/2022	Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients Ceyhan-Birsoy O, Jayakumaran G, Kemel Y, …, Zehir A, and Mandelker D	Genome Med.
10/2022	Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing Ptashkin RN, Ewalt MD, Jayakumaran G, …, Zehir A, and Arcila ME	Biorxiv
6/2021	Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS Rose Brannon A, Jayakumaran G, Diosdado M, …, Zehir A, and Benayed R	Nat. Commun.
2/2021	Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors Fiala EM, Jayakumaran G, Mauguen A, …, Zehir A, and Walsh MF	Nature Cancer
10/2021	Clonal hematopoiesis is associated with risk of severe Covid-19 Bolton KL, Koh Y, Foote MB, …, Kim NJ, and Zehir A	Nat. Commun.
9/2020	MiMSI - a deep multiple instance learning framework improves microsatellite instability detection from tumor next-generation sequencing Ziegler J, Hechtman JF, Ptashkin R, …, Fuchs TJ, and Zehir A	Biorxiv
11/2020	Cancer therapy shapes the fitness landscape of clonal hematopoiesis Bolton KL, Ptashkin RN, Gao T, …, Zehir A, and Papaemmanuil E	Nat. Genet.
11/2018	Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors Ptashkin RN, Mandelker DL, Coombs CC, …, Berger MF, and Zehir A	Jama Oncol
9/2017	Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes Coombs CC, Zehir A, Devlin SM, …, Levine RL, and Berger MF	Cell Stem Cell
6/2017	Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients Zehir A, Benayed R, Shah RH, …, Ladanyi M, and Berger MF	Nat. Med.
10/2017	Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data Middha S, Zhang L, Nafa K, …, Zehir A, and Hechtman JF	Jco Precis Oncol
5/2015	Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology Cheng DT, Mitchell TN, Zehir A, …, Ladanyi M, and Berger MF	J. Mol. Diagn.